神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2021 ACR适宜性标准：晕厥

2021-05-18 美国放射学会 J Am Coll Radiol.2021 May;18(5S):S229-S238.

晕厥

2021年5月，美国放射学会(ACR)发布了晕厥的适应性影像学检查标准。晕厥及其先兆症状是急诊常见情况，其病因多样。本文主要针对晕厥的相关影像学检查评估提供指导建议。

中文标题：

2021 ACR适宜性标准：晕厥

英文标题：

ACR Appropriateness Criteria® Syncope

发布机构：

美国放射学会

发布日期：

2021-05-18

简要介绍：

2021年5月，美国放射学会(ACR)发布了晕厥的适应性影像学检查标准。晕厥及其先兆症状是急诊常见情况，其病因多样。本文主要针对晕厥的相关影像学检查评估提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ACR适宜性标准：晕厥.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9a8b31c002115607, title=2021 ACR适宜性标准：晕厥, enTitle=ACR Appropriateness Criteria® Syncope, guiderFrom=J Am Coll Radiol.2021 May;18(5S):S229-S238., authorId=0, author=, summary=2021年5月，美国放射学会(ACR)发布了晕厥的适应性影像学检查标准。晕厥及其先兆症状是急诊常见情况，其病因多样。本文主要针对晕厥的相关影像学检查评估提供指导建议。, cover=https://img.medsci.cn/2021626/1624708257926_2020535.jpg, journalId=0, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会（American College of Radiology）拥有会员超过34,000名，包括美国放射医师，放射肿瘤学家，物理学家介入医师及核医学医师。其指南按放射检查的方法分类，共十组，每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Tue May 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年5月，美国放射学会(ACR)发布了晕厥的适应性影像学检查标准。晕厥及其先兆症状是急诊常见情况，其病因多样。本文主要针对晕厥的相关影像学检查评估提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=10643, tagName=晕厥)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10643, guiderKeyword=晕厥, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4848, appHits=114, showAppHits=0, pcHits=423, showPcHits=4732, likes=0, shares=7, comments=6, approvalStatus=1, publishedTime=Sat Jun 26 20:07:40 CST 2021, publishedTimeString=2021-05-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jun 26 19:57:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 15:51:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ACR适宜性标准：晕厥.pdf)])
2021 ACR适宜性标准：晕厥.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=997464, encodeId=34a899e46439, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Thu Jul 08 09:43:30 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977874, encodeId=7a069e7874c1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:29:46 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977390, encodeId=5c4d9e739031, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84615534908, createdName=ms5000000415417449, createdTime=Sun Jun 27 20:02:32 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977186, encodeId=91279e71860a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/8ca43c692f754cf3baabc73594737679/87ce0123aace45b2b36c239ea054987c.jpg, createdBy=e5055287837, createdName=14858760m83暂无昵称, createdTime=Sat Jun 26 23:58:55 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-07-08 乌拉小草

    可以

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=997464, encodeId=34a899e46439, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Thu Jul 08 09:43:30 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977874, encodeId=7a069e7874c1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:29:46 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977390, encodeId=5c4d9e739031, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84615534908, createdName=ms5000000415417449, createdTime=Sun Jun 27 20:02:32 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977186, encodeId=91279e71860a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/8ca43c692f754cf3baabc73594737679/87ce0123aace45b2b36c239ea054987c.jpg, createdBy=e5055287837, createdName=14858760m83暂无昵称, createdTime=Sat Jun 26 23:58:55 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-06-29 李曌

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=997464, encodeId=34a899e46439, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Thu Jul 08 09:43:30 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977874, encodeId=7a069e7874c1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:29:46 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977390, encodeId=5c4d9e739031, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84615534908, createdName=ms5000000415417449, createdTime=Sun Jun 27 20:02:32 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977186, encodeId=91279e71860a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/8ca43c692f754cf3baabc73594737679/87ce0123aace45b2b36c239ea054987c.jpg, createdBy=e5055287837, createdName=14858760m83暂无昵称, createdTime=Sat Jun 26 23:58:55 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-06-27 ms5000000415417449

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=997464, encodeId=34a899e46439, content=可以, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210627/96b10214fe8f4a039febb3ea9891a8aa/df59dd3a997242479937a4f3feae3b05.jpg, createdBy=052c5526600, createdName=乌拉小草, createdTime=Thu Jul 08 09:43:30 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977874, encodeId=7a069e7874c1, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/bf9e13628a7540c8bdded17349a84dcd/7595f30ec58b494c9ad54fa09af51de8.jpg, createdBy=3c925261712, createdName=李曌, createdTime=Tue Jun 29 11:29:46 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977390, encodeId=5c4d9e739031, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84615534908, createdName=ms5000000415417449, createdTime=Sun Jun 27 20:02:32 CST 2021, time=2021-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977186, encodeId=91279e71860a, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/8ca43c692f754cf3baabc73594737679/87ce0123aace45b2b36c239ea054987c.jpg, createdBy=e5055287837, createdName=14858760m83暂无昵称, createdTime=Sat Jun 26 23:58:55 CST 2021, time=2021-06-26, status=1, ipAttribution=)]
    2021-06-26 14858760m83暂无昵称

    #学习#

    0

相关指南

2019美国心脏协会和美国红十字会急救重点更新：晕厥

美国心脏协会(AHA,American Heart Association) · 2019-11-15

晕厥诊断与治疗中国专家共识（2018）

中华心血管病杂志编辑委员会 · 2019-02-20

2018 ESC指南：晕厥的诊断和管理

欧洲心脏病学会(ESC,European Society of Cardiology) · 2018-03-20

2017美国晕厥指南解读

暂未更新 · 2017-03-30

【精品指南】2017 ACC/AHA/HRS指南：晕厥患者的评估和管理要点与解读

暂未更新 · 2017-03-28

2017 ACC/AHA/HRS指南：晕厥患者的评估和管理

美国心脏病学会(ACC,American College of Cardiology) · 2017-03-09

拓展阅读

2009 ESC 晕厥的诊断与治疗指南

欧洲心脏病学会(ESC,European Society of Cardiology) · 2009-11-01

2011 CCS意见书：晕厥诊断的标准方案

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2011-03-30

晕厥诊断与治疗中国专家共识（2014年更新版）

中国老年学学会心脑血管病专业委员会 · 2014-11-13

2016 儿童晕厥诊断指南

中华医学会儿科学分会心血管学组 · 2016-04-30

2016 CCS/CPCA立场声明：儿童晕厥的管理

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2016-10-01

2017 ACC/AHA/HRS指南：晕厥患者的评估和管理

美国心脏病学会(ACC,American College of Cardiology) · 2017-03-09